slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 219,271-219,300
Pages 10,126
Rows per page 30
Component
219,271-219,300 of 303,780
06
The slide uses a 3x2 grid layout to present key performance indicators and strategic updates.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
07
Includes a disclaimer about rounding differences.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
08
The slide contains two distinct tables: one for absolute member counts and one for percentage of total members.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
09
Includes a disclaimer about rounding differences.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
10
Includes a footnote regarding the definition of Adjusted EBITDA and rounding.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
The slide presents two distinct tables: one for percentage ratios and one for YoY basis point changes.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Pareto Focus1 hit
12
The slide uses lettered callouts (A-F) to map specific adjustments to their definitions on the right.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations 1 hit
13
Includes a table of medical centers by state and a summary table of key metrics (states, centers, members) over time.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations 1 hit
01
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
02
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
03
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style chart to represent drug development progress.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
05
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
06
Includes a Kaplan-Meier survival curve, an anatomical illustration of tumor locations, and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
BICR = Blinded Independent Central Review; RANO = Response Assessment in Neuro-Oncology; HGG = High-Grade Glioma; LGG = Low-Grade Glioma; SAEs = Serious Adverse Events.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
08
The slide details specific inclusion/exclusion criteria, including age, mutation status, prior therapy, and washout periods.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
09
The slide highlights clinical trial results with specific response and disease control rates for two different RANO criteria.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
10
The chart is a waterfall plot (often called a swimmer plot or spider plot in oncology, though technically a waterfall).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
11
The chart is a waterfall plot showing Best % Change in SPD from Baseline. The legend indicates PS scores (060-100).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
13
Data presented in two tables comparing healthy adult dose escalation vs glioma patient safety profiles.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide highlights the correlation between RANO response criteria and improved clinical outcomes in H3 K27M-mutant DMG patients.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The table uses a color-coded heatmap to highlight favorable (green) vs unfavorable (pink) characteristics of clinical trial data.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
16
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
17
The slide uses a process flow diagram to illustrate the trial structure.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
18
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
19
The slide details specific event counts and target hazard ratios for OS and PFS endpoints.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) result in higher efficacy (lower cell viability) at lower concentrations compared to 24 hours.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
21
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
22
The slide uses a medical illustration of the brain to map patient counts and positivity rates to specific anatomical regions.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
23
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit